To date, lecanemab is the first traditional approval of a treatment for Alzheimer’s disease. Lecanemab holds promise for patients in early stages of the disease.
Pittsburgh, PA (PRWEB) October 03, 2022 Allegheny Health Network (AHN) has been named one of four recipients of the Henry L. Hillman Foundation “Healthy